Effect of Brown Rice on the Risk Factors for Metabolic Syndrome

NCT ID: NCT02321553

Last Updated: 2015-05-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

7 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-04-30

Study Completion Date

2015-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to determine the effect of consumption of brown rice on the risk factors of metabolic syndrome (MetS) as compared to consumption of white rice. Brown and white rice will be provided in the form of rice cakes and 100g will be consumed per day for 5 weeks each. The investigators hypothesize that brown rice will have beneficial effects as it is rich in fiber and also phytochemicals.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a 2-way cross-over, randomized, placebo controlled, pilot feasibility study to determine the effect of brown rice on the risk factors of metabolic syndrome (MetS). Eligible subjects (n = 9) with the MetS (\>50 yr, post-menopausal women and men) will be randomized to receive either brown rice cakes (100 g/d) as treatment or white rice cake as placebo during each 5-wk intervention phase with a 2-wk washout between phases. Subjects will visit Tufts Medical Center for all study visits, at the end of baseline (first 2 week run in phase) and weeks 7, 9 and 14, which will include a 12 hour fasting blood draw. Two sets of three 24 hour dietary recalls will be conducted during the intervention phases. Fasting blood samples will be analyzed for 1) oxidative stress markers (vitamin E concentrations, total antioxidant capacity, and lipid peroxidation product), 2) blood lipid profiles and 3) metabolic risk factors such as plasma glucose, insulin, inflammatory cytokines.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Metabolic Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Brown Rice

Eat 100g of brown rice cake (3 packets) per day for 5 weeks

Group Type EXPERIMENTAL

Brown rice

Intervention Type OTHER

brown rice cake

White Rice

Eat 100g of white rice cake (3 packets) per day for 5 weeks

Group Type EXPERIMENTAL

White rice

Intervention Type OTHER

white rice cake

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Brown rice

brown rice cake

Intervention Type OTHER

White rice

white rice cake

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men \& postmenopausal women, aged \>50 years
* BMI \>30 kg/m2 and/or waist/hip ratio \>0.9 for men, \>0.85 for women
* plus any two of the following four MetS factors
* Fasting plasma TG: 150-400 mg/dL (1.7 - 4.52 mmol/L)
* Fasting plasma HDL cholesterol: \<40 mg /dL (1.03 mmol/L) for men, \<50 mg/dL (1.29 mmol/L) for women
* Blood pressure: SBP, 130-160 mmHg and/or DBP 85-95 mmHg
* Fasting plasma glucose: fasting blood glucose 100-125 mg/dL (5.55- 6.94 mmol/L) and no medication for blood glucose regulation and no use of insulin

Exclusion Criteria

* Cigarette smoking and/or nicotine replacement use
* Individuals taking estrogen
* Use of blood glucose lowering medications or insulin
* Regular use (\>2x/wk) of any stomach acid-lowering medications or laxatives
* Regular use (\>2x/wk) of medication for inflammation
* Regular use of medication for hypercoagulation
* Cardiovascular (heart) disease
* Gastrointestinal disease
* Renal or chronic kidney disease
* Endocrine disease: including diabetes, untreated thyroid disease
* Rheumatoid arthritis
* Active treatment for any type of cancer, except basal cell carcinoma, within 1 year prior to study admission
* Systolic blood pressure \>160 mmHg and/or diastolic blood pressure \>95 mmHg
* Regular use of oral steroids except topical OTC steroids
* Regular daily intake of ≥2 alcoholic drinks
* Infrequent (\<3/wk) or excessive (\>3/d) number of regular bowel movements
* Illicit drug use
* Vegetarians
* No fish oil supplements (including cod liver oil) for one month prior to study admission
* No dietary supplements, including those containing any vitamins, minerals, herbs, plant concentrates (including garlic, gingko, St. John's wort) or homeopathic remedies, for one month prior to study admission
* On or planning a weight reducing regimen using a dietary approach of dietary supplements
Minimum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tufts University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Oliver Chen

Scientist I

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Oliver Chen, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

Tufts University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinical and Translation Research Center, Tufts Medical Center

Boston, Massachusetts, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

11066

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Diet and Health in Adults With Metabolic Syndrome
NCT03935048 ACTIVE_NOT_RECRUITING NA
Soy Nut Study on Markers of Health
NCT01173380 COMPLETED NA